Phenothiazine and butyrophenone intoxication in children.
Knight ME, Roberts RJ.
Pediatr Clin North Am. 1986 Apr;33(2):299-309. doi: 10.1016/s0031-3955(16)35003-9.
Preparation and characteristics of antibacterial chitosan films modified with N-halamine for biomedical application.
Chylińska M, Kaczmarek H, Burkowska-But A.
Colloids Surf B Biointerfaces. 2019 Apr 1;176:379-386. doi: 10.1016/j.colsurfb.2019.01.013. Epub 2019 Jan 5.
Neuroleptic malignant syndrome in a COVID-19 patient.
Kajani R, Apramian A, Vega A, Ubhayakar N, Xu P, Liu A.
Brain Behav Immun. 2020 Aug;88:28-29. doi: 10.1016/j.bbi.2020.05.042. Epub 2020 May 18.
Drug-induced chronic liver disease, with emphasis on chronic active hepatitis.
Seeff LB.
Semin Liver Dis. 1981 May;1(2):104-15. doi: 10.1055/s-2008-1040723.
Dantrolene for Treatment of Suspected Neuroleptic Malignant Syndrome.
Whyte CJ, Rosini JM.
J Emerg Nurs. 2018 Mar;44(2):207-209. doi: 10.1016/j.jen.2017.11.008.
Fosphenytoin-induced dyskinesias in an infant with Sturge-Weber syndrome.
Thodeson DM, Reiber DC, Dolce AM, Sirsi D.
Neurology. 2016 Apr 19;86(16):1561-2. doi: 10.1212/WNL.0000000000002595.
Dantrolene and 'ecstasy' overdose.
Larner AJ.
Anaesthesia. 1993 Feb;48(2):179-80.
Myristicin and phenytoin toxicity in an infant.
Sivathanu S, Sampath S, David HS, Rajavelu KK.
BMJ Case Rep. 2014 Jun 5;2014:bcr2013203000. doi: 10.1136/bcr-2013-203000.
Design, synthesis, anticonvulsant, and antiarrhythmic properties of novel N-Mannich base and amide derivatives of beta-tetralinohydantoin.
Czopek A, Byrtus H, Zagórska A, Siwek A, Kazek G, Bednarski M, Sapa J, Pawłowski M.
Pharmacol Rep. 2016 Oct;68(5):886-93. doi: 10.1016/j.pharep.2016.04.018. Epub 2016 May 21.
Treatment of Toxin-Related Status Epilepticus With Levetiracetam, Fosphenytoin, or Valproate in Patients Enrolled in the Established Status Epilepticus Treatment Trial.
Coralic Z, Kapur J, Olson KR, Chamberlain JM, Overbeek D, Silbergleit R.
Ann Emerg Med. 2022 Sep;80(3):194-202. doi: 10.1016/j.annemergmed.2022.04.020. Epub 2022 Jun 17.
